Donovan Joanne M.'s Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Aug 14, 2025
- Accession no.
- 0001562180-25-005794
- Filed
- Aug 14, 2025
- Trade date
- Aug 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $38.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Donovan Joanne M.CIK 0001644087 | Officer (CMO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | MOption exerciseAcquired | +5,781 | $0.00 | $0 | 28,223 | Direct | |
| Aug 12, 2025 | Common Stock | SSaleDisposed | −2,862 | $13.39 | −$38,322.18 | 25,361 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | MOption exerciseDisposed | −5,781 | $0.00 | $0 | 17,344 | Direct | |
| Aug 12, 2025 | Common Stock | AGrant or awardAcquired | +28,125 | $0.00 | $0 | 28,125 | Direct | |
| Aug 12, 2025 | Common Stock | AGrant or awardAcquired | +168,750 | $0.00 | $0 | 168,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.